Company / Current Liabilities
Aurinia Pharmaceuticals Inc. Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$93.7M
FY2025
5-year range
$40.6M / $97.8M
FY2021-FY2025
Trend
-4.1%
vs FY2024
Sector context
#101 of 213
Health Care
What the data says
At $94M, Aurinia Pharmaceuticals Inc.'s current liabilities ranks #113 of 213 in the Health Care sector. Increased from $77M to $94M over the past 2 years.
Based on SEC 10-K filings.
$94M in FY2025 with a 5-year CAGR of +24.0%.
Increased from $77M to $94M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +26.7%
- 5-Year CAGR
- +24.0%
- 10-Year CAGR
- -
Sector benchmark
#113 of 213 in Health CareTop 53% of 213This company $93.7M Sector average $1.6B
▼
-94.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +24.0%, indicating consistent growth.
- In FY2025, current liabilities decreased 4.1% year-over-year.
- Ranks #101 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $93.7M | -4.1% |
| FY2024 | $97.8M | +26.7% |
| FY2023 | $77.2M | +67.4% |
| FY2022 | $46.1M | +13.4% |
| FY2021 | $40.6M | +27.0% |
| FY2020 | $32.0M | +183.3% |
| FY2019 | $11.3M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026